APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL
Project Number2R01HL035068-07A1
Contact PI/Project LeaderKAUFMAN, DAVID W
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION: (Adapted from Investigator's Abstract) An existing
case-control study of aplastic anemia in Thailand will be extended and
modified to explore new hypotheses raised thus far and to provide more
definitive results for previously borderline findings. New information will
be collected and the data collection network will be reduced to a single
hospital in Bangkok and eight hospitals in Khonkaen, a rural region in the
northeast. Incident cases will be identified prospectively and reviewed by
study hematologists to confirm the diagnoses. Suitable hospital controls
(e.g., patients with trauma and other acute conditions) will be matched to
cases for age, sex, and the time of hospitalization. Subjects will be
interviewed to obtain information on occupational and chemical exposures,
farming practices, sanitation, drug use, personal data, and relevant medical
history. Blood samples will be collected from all cases and at least one
control per case, and stored for evaluation of future hypotheses. A total
of 195 cases and 780 controls will be enrolled.
Hypotheses to be evaluated with the new data include the following: whether
an association with grain farming that explains a substantial proportion of
cases is due to soil exposure rather than a chemical agent; elucidation of
an association with occupational exposure to solvents, with a focus on
details of the specific solvents used; the possibility that poor sanitation
increases the risk, suggested by associations with low socioeconomic status
and hepatitis A; and a more detailed evaluation of occupation. The new
subjects will be combined with the 284 cases and 1174 controls already
enrolled to conduct a detailed investigation of specific agricultural
pesticides, to explore an apparent lack of association with chloramphenicol,
and to evaluate other borderline results concerning drugs (e.g.,
mebendazole).
The new phase of data collection has already begun with support from other
sources, which will cover 2.5 years; the proposed study will cover the two
additional years of data collection and the analysis. The investigators
state that this large study has proven to be feasible, valid, and
informative, with ten papers already published or in press, and one
submitted. They further state that completion of the project as proposed
will maximize its value and be more efficient than a new study.
No Sub Projects information available for 2R01HL035068-07A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01HL035068-07A1
Patents
No Patents information available for 2R01HL035068-07A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01HL035068-07A1
Clinical Studies
No Clinical Studies information available for 2R01HL035068-07A1
News and More
Related News Releases
No news release information available for 2R01HL035068-07A1
History
No Historical information available for 2R01HL035068-07A1
Similar Projects
No Similar Projects information available for 2R01HL035068-07A1